Загрузка...

Initial Testing (Stage 1) of LCL161, a SMAC Mimetic, by the Pediatric Preclinical Testing Program

LCL161, a SMAC mimetic, was tested against the PPTP in vitro panel (1.0 nM to 10.0 μM) and the PPTP in vivo panels (30 mg/kg or 75 mg/kg [solid tumors] or 100 mg/kg [ALL]) administered orally twice weekly. LCL161 showed a median relative IC(50) value of >10 μM, being more potent against several l...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Houghton, Peter J., Kang, Min H., Reynolds, C. Patrick, Morton, Christopher L., Kolb, E. Anders, Gorlick, Richard, Keir, Stephen T., Carol, Hernan, Lock, Richard, Maris, John M., Billups, Catherine A., Smith, Malcolm A.
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3253328/
https://ncbi.nlm.nih.gov/pubmed/21681929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23167
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!